[慢性病患者的维生素D供应与某些蛋白质分数之间的关系]
László Kovács1,2, Eszter Dóra Horváth1, Renáta Pótáriné Kispál3
11 Vas Vármegyei Markusovszky Egyetemi Oktatókórház, Általános Belgyógyászati Osztály Szombathely Magyarország.
Orvosi hetilap
|July 28, 2024
概括
慢性病患者,尤其是腹腔透析患者,往往会经历越来越严重的维生素D缺乏. 较高的维生素D3剂量至关重要,而高的α-1球蛋白表明透析和非透析病例的缺乏.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 临床化学 临床化学
背景情况:
- 慢性病 (CKD) 经常与严重的维生素D缺乏有关.
- 通过免疫检测测测量的血清25-基维生素D水平是诊断的关键,但受血清蛋白质的影响.
- 了解血清蛋白与CKD中维生素D状态之间的相互作用至关重要.
研究的目的:
- 为了研究血清蛋白和维生素D状态在维生素D3原始的CKD患者之间的关系.
- 评估透析方式 (腹腔膜与血液透析) 如何影响这些关系.
- 探索维生素D水平,副甲状腺激素和蛋白质配置文件之间的相关性.
主要方法:
- 对103名CKD患者 (非透析,腹腔透析,血液透析) 的血清分析,检测25-氧维生素D,维生素D结合蛋白,,总蛋白,白蛋白和电泳性蛋白质部分.
- 使用第二代和第三代测试测量完整的偏激素.
- 统计分析以确定相关性和群体差异.
主要成果:
- 所有CKD患者都表现出维生素D缺乏 (86-100%跨组).
- 与非透析患者相比,腹膜透析患者的25-氧维生素D,,总蛋白和更高的维生素D结合蛋白水平较低.
- 在腹腔透析患者中证实了25-基维生素D和完整的副激素之间的负相关性,并在血液透析患者中进行了第三代测定.
- 高水平的α-1球蛋白与透析和非透析患者的维生素D缺乏有关.
结论:
- 维生素D缺乏在CKD中很普遍,并且可以在透析,特别是腹腔透析中恶化,需要增加维生素D3补充剂.
- 高水平的α-1球蛋白是CKD患者维生素D缺乏症的标志物.
- 透析,尤其是腹腔透析,会改变维生素D结合蛋白和其他血清蛋白水平.
- 原生维生素D的给药对于治疗CKD中的二次性副甲状腺功能障碍很重要.
- 建议使用第三代测试来验证血液透析中维生素D与副甲状腺激素之间的关系.
相关概念视频
01:23Role of Skin in Vitamin D Synthesis
5.1K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
5.1K
01:25Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
50
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
50
01:11Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77
01:21Skeleton and Calcium Homeostasis
4.4K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.4K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
137
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
137